Waller Lansden Dortch & Davis, LLP represented shareholders of AIM Healthcare Services, Inc. in the sale of equity in the company and certain affiliates to Ingenix.  Terms of the all-cash transaction, which was finalized on June 1, 2009, were not disclosed.

AIM Healthcare Services, Inc. provides claims management services for government and commercial payers of healthcare benefits and healthcare providers in the United States.  Ingenix is a wholly owned subsidiary of United Health Group (NYSE:UNH) and provides payment accuracy solutions for healthcare payers and hospitals.  In a statement following the transaction, James Sohr, president of AIM Healthcare Services, Inc. said “AIM and Ingenix share a commitment to reducing costs and simplifying the healthcare system.  Ingenix’s culture of innovation and growth complements our own, and being part of Ingenix will provide exciting new opportunities for or employees.”  The press release issued by Ingenix describing the transaction is available at this link.

Waller Lansden Dortch & Davis, LLP was recently recognized by Modern Healthcare as the third largest healthcare law firm in the United States.  The firm has more than 40 years of experience advising hospital companies; outpatient services providers; hospice, home health and senior living companies; and healthcare technology companies.  Representing healthcare providers throughout the United States, Waller Lansden provides counsel in mergers and acquisitions, securities and commercial finance transactions, regulatory compliance matters; real estate transactions; intellectual property issues; labor and employment matters; commercial litigation and tax.  The firm is headquartered in Nashville, Tenn., with offices in Los Angeles and Birmingham, Ala.  For more information please visit www.wallerlaw.com.


The opinions expressed in this bulletin are intended for general guidance only. They are not intended as recommendations for specific situations. As always, readers should consult a qualified attorney for specific legal guidance.